Log in

LON:PRMProteome Sciences Share Price, Forecast & News

GBX 2.92
-0.08 (-2.67 %)
(As of 04/7/2020 01:15 AM ET)
Add
Compare
Today's Range
2.65
Now: GBX 2.92
3.10
50-Day Range
2.64
MA: GBX 3.22
3.60
52-Week Range
2.25
Now: GBX 2.92
4.30
Volume485,560 shs
Average Volume88,695 shs
Market Capitalization£8.62 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, isobaric reagents, and biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes. It primarily serves pharmaceutical companies and other sectors, including academic research. The company was incorporated in 1993 and is headquartered in London, the United Kingdom.
Read More
Proteome Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.40 out of 5 stars


Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-70432116

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£3.47 million
Cash FlowGBX 0.28 per share
Book ValueGBX (1.40) per share

Profitability

Miscellaneous

Employees29
Market Cap£8.62 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PRM News and Ratings via Email

Sign-up to receive the latest news and ratings for PRM and its competitors with MarketBeat's FREE daily newsletter.


Proteome Sciences (LON:PRM) Frequently Asked Questions

How has Proteome Sciences' stock been impacted by COVID-19 (Coronavirus)?

Proteome Sciences' stock was trading at GBX 3.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PRM stock has decreased by 10.2% and is now trading at GBX 2.92. View which stocks have been mosted impacted by Coronavirus.

Has Proteome Sciences been receiving favorable news coverage?

Media stories about PRM stock have trended very negative this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Proteome Sciences earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutProteome Sciences.

Who are some of Proteome Sciences' key competitors?

Some companies that are related to Proteome Sciences include VolitionRX (VNRX), Spectral Medical (EDT), ANGLE (AGL), DiaSorin (DIA), Polarityte (COOL) and Premaitha Health (NIPT).

What other stocks do shareholders of Proteome Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL), Boohoo Group (BOO), Mondi (MNDI), Petrofac (PFC), Lloyds Banking Group (LLOY), Falanx Group (FLX), Quanterix (QTRX), Centrica (CNA), Cyanconnode (CYAN) and Eckoh (ECK).

Who are Proteome Sciences' key executives?

Proteome Sciences' management team includes the following people:
  • Dr. Jeremy Rupert Michael Haigh, CEO & Exec. Director (Age 58)
  • Dr. Ian H. Pike, Chief Scientific Officer & Exec. Director
  • Mr. Richard Paul Dennis, Chief Commercial Officer & Exec. Director (Age 60)
  • Mr. Stefan Fuhrmann, Interim Fin. Director
  • Dr. Josef Schwarz, Chief Compliance Officer

What is Proteome Sciences' stock symbol?

Proteome Sciences trades on the London Stock Exchange (LON) under the ticker symbol "PRM."

How do I buy shares of Proteome Sciences?

Shares of PRM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Proteome Sciences' stock price today?

One share of PRM stock can currently be purchased for approximately GBX 2.92.

How big of a company is Proteome Sciences?

Proteome Sciences has a market capitalization of £8.62 million and generates £3.47 million in revenue each year. Proteome Sciences employs 29 workers across the globe. View additional information about Proteome Sciences.

What is Proteome Sciences' official website?

The official website for Proteome Sciences is http://www.proteomics.com/.

How can I contact Proteome Sciences?

Proteome Sciences' mailing address is Hamilton House, Mabledon Place, LONDON, WC1H 9BB, United Kingdom. The company can be reached via phone at +44-20-70432116.

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel